Predictors of long-term progression-free survival in patients with ovarian cancer treated with niraparib in the PRIMA/ENGOT-OV26/GOG-3012 study

  1. Graybill, W.S.
  2. Pardo Búrdalo, B.
  3. O'Malley, D.M.
  4. Vergote, I.
  5. Monk, B.J.
  6. Auranen, A.
  7. Copeland, L.J.
  8. Sabbatini, R.
  9. Herzog, T.J.
  10. Follana, P.
  11. Pothuri, B.
  12. Braicu, E.I.
  13. McCormick, C.
  14. Yubero, A.
  15. Moore, R.G.
  16. Vuylsteke, P.
  17. Raaschou-Jensen, N.
  18. York, W.
  19. Hartman, J.
  20. González-Martín, A.
Revue:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

ISSN: 1525-1438

Année de publication: 2024

Volumen: 34

Número: 7

Pages: 1041-1050

Type: Article

DOI: 10.1136/IJGC-2024-005356 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus